Levodopa + Carbidopa + Entacapona Pentafarma

Levodopa, Carbidopa, Entacapone, the active ingredient in Levodopa + Carbidopa + Entacapona Pentafarma, is a combination dopamine precursor and COMT inhibitor presented as an oral tablet for oral use. It is indicated for the management of Parkinson's disease, helping to control motor symptoms and reduce OFF periods in patients.

GNH USA supplies Levodopa + Carbidopa + Entacapona Pentafarma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levodopa/Carbidopa/Entacapone is used in the Parkinson's disease therapeutic pathway to improve motor control and reduce fluctuations. - Parkinson's disease: improves overall motor symptoms and reduces OFF time. - Parkinson's disease with wearing‑off: provides smoother dopamine levels to lessen motor fluctuations. - Early‑stage Parkinson's disease: helps maintain functional mobility and delay progression of motor complications.

Levodopa/Carbidopa/Entacapone may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Orthostatic hypotension: dizziness upon standing. - Dyskinesia: involuntary movements, especially at higher doses. - Insomnia: difficulty sleeping. - Dry mouth: reduced salivation. - Constipation: slowed bowel movements.

Serious or Rare Side Effects: - Neuroleptic malignant syndrome: high fever, muscle rigidity, autonomic instability. - Severe depression or suicidal thoughts. - Hallucinations or psychosis. - Severe arrhythmias: irregular heart rhythm. - Hepatic dysfunction: elevated liver enzymes. - Anaphylactic reaction: rare allergic response.

Before initiating therapy, clinicians should consider several safety measures. - Blood pressure monitoring: watch for orthostatic hypotension, especially in the elderly. - Psychiatric assessment: monitor for hallucinations, depression, or suicidal ideation. - Renal function: dose may need adjustment in severe renal impairment. - Abrupt discontinuation: avoid sudden stop to prevent withdrawal and worsening symptoms. - Elderly patients: start at low dose and titrate slowly. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Levodopa/Carbidopa/Entacapone can interact with several drug classes.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - Anticholinergic agents: may mask Parkinsonian symptoms. - High‑dose pyridoxine (vitamin B6): reduces levodopa efficacy.

Moderate Interactions (Monitor Closely): - SSRIs or SNRIs: potential for serotonin syndrome. - Antihypertensive drugs: additive blood pressure lowering. - Iron or calcium supplements: may decrease levodopa absorption; separate dosing times.